INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy
Gennaro Giustino1,2, MD; Robert M.A. Van der Boon3, MD, PhD; Javier Molina-Martin de Nicolas4, MD; Nicolas Dumonteil5, MD; Alaide Chieffo1, MD; Peter P.T. de Jaegere3, MD, PhD; Didier Tchetche4, MD; Bertrand Marcheix5, MD, PhD; Damien Millischer4, MD; Romain Cassagneau4, MD; Didier Carrié5, MD, PhD; Nicolas M. Van Mieghem3, MD, PhD; Antonio Colombo1*, MD
1. Department of Cardio-Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy; 2. The Icahn School of Medicine at Mount Sinai Cardiovascular Institute, New York, NY, USA; 3. Department of Interventional Cardiology, Thoraxcenter, E
Aims: We sought to evaluate the impact of permanent pacemaker (PPM) implantation on two-year mortality and one-year left ventricular ejection fraction recovery (∆LVEFR=one-year LVEF–basel